Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2019
Advances in Lead Generation
Joerg Holenz, Patrick Stoy
Clinical Pharmacology in Drug Development
|
April 10, 2026
A Randomized, Double-Blinded, Placebo-Controlled QTc Study to Evaluate BIA 28-6156 Effect on Cardiac Repolarization in Healthy Volunteers
Isa Peixoto, Dana Hilt, Teresa Carvalho, et al.
Seizure
|
June 2, 2026
Pregnancy outcomes following Eslicarbazepine acetate exposure in women with epilepsy: A global safety database analysis from clinical development to 16 years of post-marketing experience
Diogo Lopes, Valentina Di Foggia, Carolina Sousa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 24, 2025
Human metabolism of zamicastat, an oral dopamine β-hydroxylase inhibitor
Ana Isabel Loureiro, Franscisca Araújo, Carlos Fernandes-Lopes, et al.
Journal of Parkinson'S Disease
|
February 20, 2025
Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial
Joaquim J Ferreira, Miguel F Gago, Raquel Costa, et al.
European Journal of Neurology
|
January 10, 2025
Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
Joaquim J Ferreira, Olivier Rascol, Fabrizio Stocchi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 3, 2024
Metabolism and disposition of zamicastat in rats
Francisca Araújo, Maria Luisa Dória, Alexandre Beliaev, et al.
Clinical and Translational Science
|
May 24, 2024
Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial
Sang Kun Lee, Sang Ahm Lee, Seung Bong Hong, et al.
Journal of Parkinson'S Disease
|
April 17, 2026
Long-term follow up of opicapone as add-on to levodopa in Parkinson's patients without motor fluctuations
Joaquim J Ferreira, Olivier Rascol, Fabrizio Stocchi, et al.
Pharmacology Research & Perspectives
|
October 23, 2024
The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsy
Jill C Richardson, Guy A Higgins, Neil Upton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2019
Advances in Lead Generation
Joerg Holenz, Patrick Stoy
Clinical Pharmacology in Drug Development
|
April 10, 2026
A Randomized, Double-Blinded, Placebo-Controlled QTc Study to Evaluate BIA 28-6156 Effect on Cardiac Repolarization in Healthy Volunteers
Isa Peixoto, Dana Hilt, Teresa Carvalho, et al.
Seizure
|
June 2, 2026
Pregnancy outcomes following Eslicarbazepine acetate exposure in women with epilepsy: A global safety database analysis from clinical development to 16 years of post-marketing experience
Diogo Lopes, Valentina Di Foggia, Carolina Sousa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 24, 2025
Human metabolism of zamicastat, an oral dopamine β-hydroxylase inhibitor
Ana Isabel Loureiro, Franscisca Araújo, Carlos Fernandes-Lopes, et al.
Journal of Parkinson'S Disease
|
February 20, 2025
Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial
Joaquim J Ferreira, Miguel F Gago, Raquel Costa, et al.
European Journal of Neurology
|
January 10, 2025
Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
Joaquim J Ferreira, Olivier Rascol, Fabrizio Stocchi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 3, 2024
Metabolism and disposition of zamicastat in rats
Francisca Araújo, Maria Luisa Dória, Alexandre Beliaev, et al.
Clinical and Translational Science
|
May 24, 2024
Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial
Sang Kun Lee, Sang Ahm Lee, Seung Bong Hong, et al.
Journal of Parkinson'S Disease
|
April 17, 2026
Long-term follow up of opicapone as add-on to levodopa in Parkinson's patients without motor fluctuations
Joaquim J Ferreira, Olivier Rascol, Fabrizio Stocchi, et al.
Pharmacology Research & Perspectives
|
October 23, 2024
The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsy
Jill C Richardson, Guy A Higgins, Neil Upton, et al.
Page
of 2